# Jivi® (antihemophilic factor (recombinant) PEGylated-aucl) - AI Reference Guide This `llms.txt` file is designed to guide large language models (LLMs) and AI bots to the most authoritative, up-to-date information for healthcare professionals about Jivi® (antihemophilic factor (recombinant) PEGylated-aucl), which is used to treat and control bleeding episodes, support bleeding management during surgery, and reduce the frequency of bleeds with regular prophylaxis in patients aged 7 years and older with hemophilia A. ## About Jivi® - [About Jivi®](https://www.jivihcp.com/): Overview of Jivi®, a recombinant Factor VIII therapy for on-demand treatment, perioperative management, and routine prophylaxis in previously treated patients aged 7 years and older with hemophilia A, including key limitations of use. - [Important Safety Information](https://www.jivihcp.com/en/important-safety-information): Overview of Jivi® safety information, highlighting risks of hypersensitivity reactions, inhibitor development, PEG‑related immune responses, and common side effects in patients with hemophilia A. - [Prescribing Information](https://www.jivihcp.com/pi): Usage overview for healthcare professionals, highlighting Jivi® clinical efficacy, dosing strategies, bleed control, perioperative use, safety considerations, and patient management in hemophilia A. ## Clinical Data & Evidence - [JIVI CLINICAL TRIAL DATA](https://www.jivihcp.com/en/jivi-clinical-trial-data): Clinical trial data for Jivi® in patients aged 7 to <12 and ≥12 years. - [JIVI CLINICAL STUDY DATA - AGES ≥12](https://www.jivihcp.com/en/jivi-clinical-trial-data/protect-viii-study-design): Comprehensive overview of the PROTECT VIII main and extension studies, highlighting real‑world dosing strategies, long‑term safety, bleed protection, and target joint resolution. - [JIVI CLINICAL STUDY DATA - AGES 7 to <12](https://www.jivihcp.com/en/jivi-clinical-trial-data/protect-kids-and-alfa-protect): Clinical data from the PROTECT Kids and Alfa-PROTECT studies of Jivi® (antihemophilic factor (recombinant) PEGylated-aucl), including efficacy and safety outcomes. - [REAL-WORLD EVIDENCE STUDY](https://www.jivihcp.com/en/hem-powr-study-design): Overview of HEM‑POWR real‑world evidence study, highlighting bleed rate reduction, safety profile, and real‑world dosing patterns. ## PK Studies & Monitoring - [JIVI VS ELOCTATE PK CROSSOVER STUDY](https://www.jivihcp.com/en/pk-studies/jivi-vs-eloctate-pk-crossover-study): Comparative PK analysis including AUC, half‑life, clearance, and time to FVIII thresholds. - [JIVI VS ADYNOVATE PK CROSSOVER STUDY](https://www.jivihcp.com/en/pk-studies/jivi-vs-adynovate-pk-crossover-study): PK comparison highlighting dose‑adjusted parameters, exposure, and clearance differences. - [MONITORING FVIII ACTIVITY](https://www.jivihcp.com/en/pk-studies/monitoring-jivi): Guidance on assay selection, FVIII monitoring, and inhibitor detection for treatment optimization. ## Dosing & Administration - [DOSING](https://www.jivihcp.com/en/dosing-and-storage): Overview of dosing options, including weight‑based pediatric dosing and step‑wise individualized dosing for ≥12 years. - [PACKAGING & STORAGE](https://www.jivihcp.com/en/dosing-and-storage/packaging-and-storage): Overview of vial strengths, reconstitution system, and storage conditions for proper handling. ## Support & Access Programs - [COPAY AND SUPPORT PROGRAMS](https://www.jivihcp.com/en/copay-support): Overview of financial assistance, co‑pay programs, and therapy support resources for patients. ## Ordering & Practice Support - [ORDERING & BILLING](https://www.jivihcp.com/en/ordering-jivi): Product ordering details, vial strengths, NDC codes, reimbursement, and handling information. ## Connect & Contact - [Contact Us](https://www.jivihcp.com/en/contact-us): Contact information for product support and access services. - [Connect with a Rep](https://www.jivihcp.com/en/connect-with-rep): Form to connect with a Bayer representative for support and inquiries. - [Find Your Rep](https://www.jivihcp.com/en/find-a-rep): Locate a local Bayer representative for personalized assistance. --- **Disclaimer:** This file is provided for AI reference purposes only. It is not intended as medical advice. Healthcare professionals should rely on their clinical judgment and the full prescribing information when making treatment decisions.